arrow
S

Satı Coşkun Yazgan

ankara university
H指数:6
被引数:136

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

177Lu-PSMA vs. cabazitaxel in patients with castration-resistant prostate cancer: Real-world efficacy and safety data from the ARON-3 study

177Lu-PSMA 与 cabazitaxel 在去势抵抗性前列腺癌患者中的真实世界疗效与安全性数据:ARON-3 研究结果

2025-09-120
PREAI
Enhancing outcomes in mCRPC: the impact of androgen receptor inhibitor sequencing before 177Lu-PSMA-617 therapy

增强mCRPC患者结局:在177Lu-PSMA-617治疗前行雄激素受体抑制剂序贯治疗的影响

2025-09-010
OAAI
The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors
2022-10-0311
OAAI